Radioactive Iodine: Recognizing the Need for Risk-Benefit Balance
J Clin Oncol
.
2022 May 1;40(13):1396-1399.
doi: 10.1200/JCO.22.00013.
Epub 2022 Mar 17.
Authors
Andrew M McDonald
1
2
,
Brenessa Lindeman
3
,
Deepti Bahl
4
Affiliations
1
Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL.
2
Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL.
3
Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.
4
Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL.
PMID:
35298297
DOI:
10.1200/JCO.22.00013
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Iodine Radioisotopes* / adverse effects
Risk Assessment
Thyroid Neoplasms* / radiotherapy
Thyroid Neoplasms* / surgery
Thyroidectomy
Substances
Iodine Radioisotopes